Certuity’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$464K Buy
2,573
+479
+23% +$92.4K 0.03% 312
2025
Q4
$385K Buy
2,094
+127
+6% +$22.3K 0.02% 336
2025
Q3
$302K Sell
1,967
-187
-9% -$28.3K 0.02% 393
2025
Q2
$301K Sell
2,154
-34
-2% -$4.76K 0.03% 295
2025
Q1
$322K Buy
2,188
+82
+4% +$11.9K 0.03% 248
2024
Q4
$276K Sell
2,106
-34
-2% -$4.76K 0.03% 275
2024
Q3
$333K Buy
2,140
+414
+24% +$66.8K 0.04% 240
2024
Q2
$269K Buy
+1,726
New +$260K 0.02% 282

Other funds holding AZN

Certuity's AZN Position: Q1 2026 in Review

Certuity increased its AstraZeneca (AZN) stake by 23% in Q1 2026, buying an estimated $92.4K and bringing the position to 2,573 shares worth $464K. The position accounts for 0.03% of the portfolio, ranked #312.

Certuity first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Certuity held 2,573 shares of AstraZeneca worth $464K as of Q1 2026.
  • Certuity bought 479 AstraZeneca shares in Q1 2026, an estimated $92.4K.
  • AstraZeneca made up 0.03% of Certuity's portfolio in Q1 2026, its #312 holding.
  • Certuity first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.